Unmissable Black Friday Deals on the ASUS Store in Canada
Unmissable Black Friday Deals on the ASUS Store in Canada
November 25, 2024 09:45 ET | ASUS Computer International
Unbeatable savings: Save up to $1,000 on the best ASUS Black Friday deals, with laptops ranging from gaming handhelds, consumer, gaming laptops, and more!
TWOZEP~1
ASUS Republic of Gamers Announces the ROG Zephyrus G16 (2024) GA605, Now Available in Canada
August 21, 2024 16:37 ET | ASUS Computer International
The new AMD Ryzen™ AI processor and NVIDIA® GeForce RTX™ 40 Series graphics brings new levels of AI-powered work and play to the Zephyrus laptop family
Fibrogen_US_Primary_logo_RGB_M01.jpg
FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-2, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis
April 03, 2023 07:00 ET | FibroGen, Inc.
- 372 IPF Patients Enrolled -- Topline Data Anticipated Mid-2024 - SAN FRANCISCO, April 03, 2023 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the completion of patient...
Fibrogen_US_Primary_logo_RGB_M01.jpg
FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-1, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis
April 20, 2022 07:00 ET | FibroGen, Inc.
- 356 IPF Patients Enrolled - - Topline Data Anticipated Mid-2023 - SAN FRANCISCO, April 20, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced completion of patient...
Fibrogen_US_Primary_logo_RGB_M01.jpg
FibroGen Announces First Patient Dosed in ZEPHYRUS, a Phase 3 Clinical Trial of Pamrevlumab for the Treatment of Patients with Idiopathic Pulmonary Fibrosis
July 22, 2019 07:00 ET | FibroGen, Inc
SAN FRANCISCO, July 22, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), today announced dosing of the first patient in the ZEPHYRUS Phase 3 clinical study of pamrevlumab in patients with...